Latest News
Conference Coverage
Tricyclics may raise fracture risk in type 2 diabetes
Although the findings are suggestive, they don’t definitively pin blame on tricyclic antidepressants alone in directly leading to fractures.
Conference Coverage
Fathers’ postpartum depression linked to children’s adversity
While not studied as much as maternal depression, paternal postpartum depression can have substantial negative impacts on children’s long-term...
Feature
Employment vs. private practice: Who’s happier?
“It used to be that fewer hospitals offered employment, so private practice was the way to go. Now, there are fewer privates because hospitals and...
From the Journals
LSD use triples among young adults with depression
The increase in LSD use was higher among those earning less than $75,000 per year.
Conference Coverage
Playing board games may slow cognitive decline, improve QoL
Playing a board game involves concentration, strategy, and intermittent rewards – all of which are good for the brain and may involve the...
Conference Coverage
Antidepressants ‘don’t blunt’ semaglutide and weight loss
“Semaglutide 2.4 mg provides an effective treatment option for weight management, regardless of antidepressant use at baseline.”
Latest News
Prior authorization software: Saves time but hurdles remain
The automation works, but the software can be costly and may not work for all practices.
Conference Coverage
Smart bracelet may predict mood changes in bipolar disorder
Each sensor collects a sample every second, resulting in highly detailed and granular data.
From the Journals
Narcolepsy med shows early promise for adult ADHD
Solriamfetol is a dopamine and norepinephrine reuptake inhibitor that shares some of the properties of current ADHD medications.
Conference Coverage
Lack of time is damaging women’s health
The one thing that is especially damaging to physical and mental health is sleep deprivation, and working mothers get less sleep than do working...
Conference Coverage
Cannabis use growing among menopausal women
Cannabis is being increasingly marketed for treating menopause-related and aging-related symptoms.